Antiretroviral therapy for HIV infection: A review of current medications and therapies

Optometry

Volumn 70, Issue 6, 1999, Pages 355-383

  Bright, David C ^a,b  

^a Los Angeles S California Coll O   (United States)

^b W Los Angeles Hlthcare C/VAGLAHS   (United States)

Author keywords

AIDS; Branched dNA(bDNA); HIV; Non nucleoside reverse transcriptase inhibitors (NNRTI); Nucleoside reverse transcriptase inhibitors (NRTI); Polymerase chain reaction (PCR); Protease inhibitors (PI); T helper cell (CD4 cell); Viral load

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

DRUG EFFECT; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; REVIEW; TREATMENT OUTCOME; VIROLOGY; VIRUS REPLICATION;

ANTI-HIV AGENTS; HIV; HIV INFECTIONS; HUMANS; TREATMENT OUTCOME; VIRUS REPLICATION;

EID: 0033146821     PISSN: 15291839     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Carpenter CC, Fischl MA, Hammer SM, et al. Antiretroviral therapy for HIV infection in 1998: updated recommendations of the International AIDS Society-USA panel. JAMA 1998;280:78-86.
2. Carpenter CC, Fischl MA, Hammer SM, et al. Antiretroviral therapy for HIV infection in 1996. Recommendations of an international panel. International AIDS Society- USA. JAMA 1996;276:146-54.
3. Carpenter CC, Fischl MA, Hammer SM, et al. Antiretroviral therapy for HIV infection in 1997. Updated recommendations of the International AIDS Society-USA panel. JAMA 1997;277:1962-9.
4. State-of-the-art conference on azidothymidine for early HIV infection. Am J Med 1990;89:335-44.
5. Sande MA, Carpenter CC, Cobbs CG, et al. Antiretroviral therapy for adult HIV-infected patients: recommendations from a state-of-the-art conference. National Institute of Allergy and Infectious Diseases State-of-the-Art Panel on Anti-retroviral Therapy for Adult HIV-infected Patients. JAMA 1993;270:2583-9.
6. Langtry HD, Campoli-Richards DM. Zidovudine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy. Drugs 1989;37:408-50.
7. Ho DD, Neumann AU, Perelson AS, et al. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 1995;373:123-6.
8. Wei X, Ghosh SK, Taylor ME, et al. Viral dynamics in human immunodeficiency virus type I infection. Nature 1995;373:117-22.
9. Coffin M. HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy. Science 1995;267:483-9.
10. Perelson AS, Neumann AU, Markowitz M, et al. HIV-1 dynamics in vivo: virion clearance rate, infected cell lifespan, and viral generation time. Science 1996;271:1582-6.
11. Mellors JW, Rinaldo CR Jr, Gupta P, et al. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 1996;272:1167-70.
12. Powderly WG, Landay A, Lederman MM. Recovery of the immune system with antiretroviral therapy: the end of opportunism? JAMA 1998;280:72-7.
13. Karavellas MP, Lowder CY, Macdonald C, et al. Immune recovery vitritis associated with inactive cytomegalovirus retinitis: a new syndrome. Arch Ophthalmol 1998;116:169-75.
14. Zegans ME, Walton RC, Holland GN, et al. Transient vitreous inflammatory reactions associated with combination antiretroviral therapy in patients with AIDS and cytomegalovirus retinitis. Am J Ophthalmol 1998;125:292-300.
15. Karavellas MP, Plummer DJ, Macdonald JC, et al. Incidence of immune recovery vitritis in cytomegalovirus retinitis patients following institution of successful highly active antiretroviral therapy. J Infect Dis 1999;179:697-700.
16. Jacobson MA, Zegans M, Pavan PR, et al. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy. Lancet 1997;349:1443-45.
17. Gilquin J, Piketty C, Thomas V, et al. Acute CMV infection in AIDS patients receiving combination therapy including protease inhibitors. Abstracts of the 4th Conference on Retroviruses and Opportunistic Infections, 1997;(abstract 354):129.
18. van den Horn GJ, Meenken C, Danner SA, et al Effects of protease inhibitors on the course of CMV retinitis in relation to CD4 + lymphocyte responses in HIV+ patients. Br J Ophthalmol 1998;82:988-90.
19. van der Horst C, Wohl DA. Cytomegalovirus (CMV) retinitisprophylaxis and treatment. Medscape HIV Clinical Management Series, Volume 4. 1999 Medscape, Inc. http://www.medscape.com/medscape/HIV/ClinicalMgmt/ CM.v04/public/index-CM.v04.html
20. Dunbar MT, McSoley JJ, Caputo MK, et al. The presence of HIV infection in a hospital-based primary care setting. Clin Eye Vision Care 1997;9:3-12.